Use of diazoxide in the treatment of ischemia retinae

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/549 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2518676

The invention relates to the use of a composition comprising diazoxide (7-chloro-3-methyl-2H-1,2,4-benzothiadiazine-1,1-dioxide) for the production of a medicament for the treatment and/or prevention of ischemia retinae and diseases associated with an ischemia retinae. The composition used for the above may also contain riluzole, or a derivative thereof with neuroprotective activity or a pharmaceutically-acceptable salt thereof.

La présente invention concerne l'utilisation d'une composition contenant du diazoxide (7-chloro-3méthyl-2H-~1, 2, 4-benzothiadiazine-1, 1-dioxide) pour la préparation d'un médicament destiné au traitement et/ou à la prévention d'une ischémie rétinienne et de maladies associées à une ischémie rétinienne. La composition utilisée dans le cadre de la présente invention peut en outre contenir du riluzole, du riluzole ou un dérivé actif en neuroprotection de celui-ci ou un sel pharmaceutiquement acceptable de celui-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of diazoxide in the treatment of ischemia retinae does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of diazoxide in the treatment of ischemia retinae, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of diazoxide in the treatment of ischemia retinae will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1777015

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.